| John William King, MD | |
|
1501 Kings Hwy, Department Of Medicine Inf Diseases, Shreveport, LA 71103-4228 | |
| (318) 675-5900 | |
| (318) 675-5907 |
| Full Name | John William King |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 1501 Kings Hwy, Shreveport, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306868856 | NPI | - | NPPES |
| 1182460 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 011870 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John William King, MD 1501 Kings Hwy, Department Of Medicine Inf Diseases, Shreveport, LA 71103-4228 Ph: (318) 675-5900 | John William King, MD 1501 Kings Hwy, Department Of Medicine Inf Diseases, Shreveport, LA 71103-4228 Ph: (318) 675-5900 |
News Archive
Ovatech, an emerging women's health-focused company, announced today that the Company's Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully completed. Ovaprene is a 'one-size-fits-all' patented, female-controlled, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously release spermiostatic and spermicidal non-drug agents over a four-week period.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE (bortezomib) for Injection, which updates the label to include additional long-term overall survival (OS) data from the VISTA trial.
A molecule that enables strong communication between our brain and muscles appears to also aid essential communication between our neurons, scientists report.
African-Americans know the signs of stroke, but concerns about medical cost, ambulance response time and unfamiliarity with the need for prompt hospital care impacted whether they called 9-1-1 immediately.
Researchers from Emory University have found that specific patterns of activity on brain scans may help clinicians identify whether psychotherapy or antidepressant medication is more likely to help individual patients recover from depression.
› Verified 6 days ago
Mansi Shah, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1455 E Bert Koun Loop, #210, Shreveport, LA 71105 Phone: 318-798-4515 Fax: 318-798-4530 | |
Pratik Agrawal, Infectious Disease Medicare: Medicare Enrolled Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 | |
Dr. Bader Alotaibi, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 2727 Hearne Ave Ste 301, Shreveport, LA 71103 Phone: 318-631-6400 | |
Paul A Rushing, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1455 E Bert Kouns Loop, Shreveport, LA 71105 Phone: 318-798-4488 Fax: 318-798-4420 | |
Sanjay Jain, Infectious Disease Medicare: Medicare Enrolled Practice Location: 510 E Stoner Ave, Primary Care (110), Shreveport, LA 71101 Phone: 318-221-8411 | |
Steven R Bailey, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 | |
Venkateswara K Rao, M.D., Infectious Disease Medicare: Medicare Enrolled Practice Location: 1501 Kings Hwy, Department Of Medicine, Shreveport, LA 71103 Phone: 318-675-5000 |